Prudential PLC Invests $516,000 in Lantheus Holdings, Inc. (NASDAQ:LNTH)

Posted by Defense World Staff on May 19th, 2023

Prudential PLC purchased a new position in shares of Lantheus Holdings, Inc. (NASDAQ:LNTH – Get Rating) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 10,129 shares of the medical equipment provider’s stock, valued at approximately $516,000.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. CWM LLC boosted its holdings in Lantheus by 82.1% in the third quarter. CWM LLC now owns 366 shares of the medical equipment provider’s stock valued at $26,000 after acquiring an additional 165 shares during the last quarter. Wipfli Financial Advisors LLC bought a new stake in Lantheus in the third quarter valued at approximately $30,000. Wolverine Asset Management LLC bought a new stake in Lantheus in the fourth quarter valued at approximately $36,000. Shell Asset Management Co. bought a new stake in Lantheus in the fourth quarter valued at approximately $80,000. Finally, Quadrant Capital Group LLC boosted its holdings in Lantheus by 435.6% in the third quarter. Quadrant Capital Group LLC now owns 1,473 shares of the medical equipment provider’s stock valued at $104,000 after acquiring an additional 1,198 shares during the last quarter. 97.62% of the stock is currently owned by institutional investors.

Lantheus Stock Down 2.0 %

Shares of NASDAQ:LNTH opened at $96.02 on Friday. The company has a quick ratio of 2.65, a current ratio of 2.80 and a debt-to-equity ratio of 1.25. Lantheus Holdings, Inc. has a twelve month low of $47.46 and a twelve month high of $100.85. The stock’s 50 day moving average is $86.11 and its 200-day moving average is $67.86.

Lantheus (NASDAQ:LNTH – Get Rating) last issued its quarterly earnings data on Thursday, May 4th. The medical equipment provider reported $1.37 earnings per share for the quarter, beating the consensus estimate of $1.21 by $0.16. Lantheus had a positive return on equity of 58.60% and a negative net margin of 1.72%. The business had revenue of $300.78 million for the quarter, compared to analysts’ expectations of $280.65 million. As a group, equities research analysts predict that Lantheus Holdings, Inc. will post 5.2 EPS for the current fiscal year.

Analysts Set New Price Targets

LNTH has been the topic of several analyst reports. Truist Financial upped their target price on Lantheus from $115.00 to $125.00 in a report on Friday, May 5th. Mizuho boosted their price target on Lantheus from $115.00 to $125.00 in a research note on Friday, May 5th. JMP Securities boosted their price target on Lantheus from $120.00 to $130.00 in a research note on Friday, May 5th. SVB Securities boosted their price target on Lantheus from $120.00 to $127.00 in a research note on Friday, May 5th. Finally, StockNews.com raised Lantheus from a “hold” rating to a “buy” rating in a research note on Thursday, May 11th. Seven investment analysts have rated the stock with a buy rating, According to MarketBeat, the company has an average rating of “Buy” and an average price target of $121.83.

Insider Buying and Selling at Lantheus

In other Lantheus news, CAO Andrea Sabens sold 7,705 shares of the firm’s stock in a transaction on Monday, March 6th. The stock was sold at an average price of $72.56, for a total transaction of $559,074.80. Following the transaction, the chief accounting officer now directly owns 63,626 shares in the company, valued at approximately $4,616,702.56. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. In other news, CEO Mary Anne Heino sold 12,189 shares of Lantheus stock in a transaction on Monday, March 6th. The stock was sold at an average price of $73.24, for a total transaction of $892,722.36. Following the sale, the chief executive officer now directly owns 729,461 shares in the company, valued at approximately $53,425,723.64. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CAO Andrea Sabens sold 7,705 shares of Lantheus stock in a transaction dated Monday, March 6th. The stock was sold at an average price of $72.56, for a total value of $559,074.80. Following the completion of the sale, the chief accounting officer now directly owns 63,626 shares of the company’s stock, valued at approximately $4,616,702.56. The disclosure for this sale can be found here. In the last three months, insiders have sold 252,403 shares of company stock worth $19,492,920. Corporate insiders own 1.50% of the company’s stock.

Lantheus Profile

(Get Rating)

Lantheus Holdings, Inc engages in the provision of diagnostic imaging and nuclear medicine products. The firm develops products that help healthcare professionals in patient management and outcomes and assists clinicians with the detection of cardiovascular disease. It operates through the U.S. and International geographical segments.